跳到主要内容

可乐Okuyemi医学博士,公共卫生硕士, 领导股权, 多样性, 和 Inclusion

阅读时间:3分钟

可乐Okuyemi医学博士,公共卫生硕士
可乐Okuyemi医学博士,公共卫生硕士

亨茨曼癌症研究所 (HCI) 在 犹他大学 (U of U) has appointed 可乐Okuyemi医学博士,公共卫生硕士, as executive director of equity, 多样性, 和包容. 在这个角色中, Okuyemi will oversee efforts across HCI’s research, 临床护理, 社区参与, 和 education programs to actively counter racism 和 promote a culture of belonging, a key strategic priority for the cancer center.

Okuyemi has had a distinguished career as a National Institutes of Health-funded researcher advancing work to eliminate health disparities 和 improve health in refugee 和 underserved populations. Okuyemi joined the 犹他大学 in 2017 as professor 和 chair of family 和 preventive medicine. Okuyemi has served as HCI senior director of 多样性 和包容 和 HCI 研究 Executive Committee member since 2017, roles in which he has overseen 公平的 access to 临床 research as part of the leadership of HCI’s NCI-designated comprehensive cancer center.

This new role exp和s his oversight to include equity, 多样性, 和包容 across the full spectrum of the HCI mission, spanning bench to bedside research, 临床护理, 人口健康科学, 以及学生培训项目. Okuyemi recently co-chaired HCI’s Commission on Equity, 多样性, 和 Inclusion. The commission was established in 2020 to advise HCI leadership on priority recommendations to enhance a more just, 公平的, 和 inclusive environment at HCI. The commission explored areas including 临床 policies, 培训, 招聘和保留实践, 安全, 和文化.

“We are extremely fortunate to have Dr. Okuyemi take on this exp和ed portfolio at HCI, where he will continue to be a leader in our quest to achieve transformational change toward a diverse, 公平的, 和 inclusive HCI community 和 society,” 玛丽·贝克尔博士, 人机交互的首席执行官. “股权的价值, 多样性, 和包容 are integral to our pledge to put the patient 和 community first as we strive to reduce the cancer burden in our state 和 region 和 deliver a cancer-free frontier.”

Okuyemi is a national leader in 培训 和 mentorship. He currently co-leads a National Cancer Institute 培训 grant dedicated to enhancing pathways for underrepresented junior high, 高中, 和 undergraduate students to pursue careers in biomedical research. The program also supports scientific 培训 for junior high teachers. In his prior role as director of cancer health disparities 在 University of Minnesota, Okuyemi was one of five principal investigators awarded a National Institutes of Health grant to establish the National 研究 Mentoring Network, a nationwide consortium of biomedical professionals 和 institutions whose goal is to provide 学员 across the biomedical, 行为, 临床, 和 social sciences with evidence-based mentorship 和 professional development programming.

“I am delighted to see HCI taking this critical step as we recognize that issues of systemic racism, 和 all forms of discrimination against employees, 学员, or patients must not be tolerated. I feel honored to have been asked to serve in this role 和 look forward to working with everyone in the HCI community as we strive towards an 公平的 和 just society,Okuyemi说.

Okuyemi earned his medical degree from the University of Ilorin in Nigeria. He completed his family medicine residency 和 master of 公共 health degree 在 University of Kansas Medical Center 和 his 公共 health research fellowship 在 Morehouse School of Medicine in Atlanta. Okuyemi begins his service as HCI executive director of equity, 多样性, 和包容 effective immediately. He will report to the 人机交互的首席执行官 in this role. Dr. Okuyemi will also retain his role as senior director 和 member of HCI’s research leadership.

媒体接触

希瑟·西蒙森
公共事务高级经理
亨茨曼癌症研究所
801 581-3194
公共.affairs@hci.犹他州.edu

About 亨茨曼癌症研究所 在 犹他大学

亨茨曼癌症研究所犹他大学 is the National Cancer Institute-designated Comprehensive Cancer Center for Utah, 爱达荷州, 蒙大拿, 内华达, 和怀俄明州. With a legacy of innovative cancer research, 突破性的发现, 世界一流的病人护理, we are transforming the way cancer is understood, 预防, 诊断, 治疗, 并存活下来. 亨茨曼癌症研究所 focuses on delivering the most advanced cancer healing 和 prevention through scientific breakthroughs 和 cutting-edge technology to advance cancer treatments of the future beyond the st和ard of care today. 大发娱乐有超过 300项公开临床试验250个研究小组 研究癌症. More genes for inherited cancers have been discovered at 亨茨曼癌症研究所 than at any other cancer center. Our scientists are world-renowned for underst和ing how cancer begins 和 using that knowledge to develop innovative approaches to treat each patient’s unique disease. 亨茨曼癌症研究所 was founded by Jon M. 和卡伦·亨茨曼.

媒体资源

癌症影响着大发娱乐所有人.